Trials / Completed
CompletedNCT01813383
Clinical Relevance of Typing HLA-DR7-DQ2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 92 (actual)
- Sponsor
- Corporacion Parc Tauli · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Celiac disease patients with HLA-DR7-DQ2 haplotype have the same histological, analytical and clinical behaviour as patients with HLA-DR3-DQ2 haplotype.
Conditions
- Celiac Disease Patients Following Recommendations of ESPGHAN
- HLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | There is not any intervention |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2012-12-01
- Completion
- 2013-03-01
- First posted
- 2013-03-19
- Last updated
- 2013-03-19
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01813383. Inclusion in this directory is not an endorsement.